Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average twelve-month […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares. The stock had previously closed at $15.09. Analyst Upgrades and Downgrades Several analysts recently weighed in on […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares traded. The stock had previously closed at $15.09. Analysts Set New Price Targets Several brokerages have […]
AIGH Capital Management LLC lessened its stake in shares of TFF Pharmaceuticals, Inc. (NASDAQ:TFFP – Free Report) by 98.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 29,482 shares of the company’s stock after selling 2,625,753 shares during the period. AIGH Capital Management LLC’s holdings in TFF Pharmaceuticals were worth $207,000 as of […]
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reduced their price objective on CASI Pharmaceuticals from $12.00 to $6.00 and set a buy rating on the stock in a […]